Aires Research Methodology: How Studies Are Designed and Evaluated

A guide to the research standards, study designs, and evaluation criteria used across the 60+ published studies on Aires Lifetune technology.

Overview

The Aires research corpus spans 33 years (1992-2025), 13+ institutions, and 6 countries. Across this body of work, multiple study designs have been employed — from single-subject case studies to multi-stage controlled animal experiments to Springer peer-reviewed computer simulations. This page explains what each methodology involves, what it measures, and how to evaluate its evidentiary weight.

Study Design Categories

1. Double-Blind, Placebo-Controlled Human Studies

What it means: Neither the subject nor the experimenter knows whether the active device or a sham (placebo) device is being used during any given test session. Results from active and placebo conditions are compared statistically.

Why it matters: Eliminates both subject expectation effects (placebo response) and experimenter bias simultaneously. The highest-quality evidence design for individual-level biological claims.

In the Aires corpus: Dr. Magda Havas (Trent University, Canada) conducted two double-blind, placebo-controlled cardiovascular case studies in 2015. Measurement instruments used (MaxPulse, FDA Class II; GDV Bio-Well) are calibrated medical devices.

Studies: Havas Case Study 1 (2015), Havas Case Study 2 (2015).

2. Controlled EEG Studies (Within-Subject Comparison)

What it means: EEG measurements are taken from the same subject in multiple conditions: baseline (no phone), phone exposure, and phone exposure with Aires device. Changes in brain wave parameters between conditions are measured and compared.

Why it matters: Within-subject designs control for individual variation in baseline brain activity. The consistency of findings across 9 separate EEG studies conducted over 22 years (2003-2025) by independent research groups strengthens the evidence considerably.

In the Aires corpus: Nine EEG studies, primarily conducted at the Pavlov Institute of Physiology (RAS) and the Military Medical Academy (St. Petersburg). Measurement instrument: standard clinical EEG systems.

Studies: EEG Research Cluster.

3. Controlled Animal Model Studies (Randomized Groups)

What it means: Animals (typically Wistar rats or Sprague-Dawley rats) are randomly assigned to control groups (no EMF exposure), EMF-exposure groups, and EMF + Aires device groups. Biological endpoints are measured in all groups and compared statistically.

Why it matters: Animal models allow measurement of biological endpoints (chromosome aberrations, blood cell counts, HSP70 expression, learning behavior) that would be ethically difficult or impossible to measure invasively in humans. Rodent models are the standard preclinical research platform in bioelectromagnetics.

In the Aires corpus: The IFRAN program at the Pavlov Institute ran five successive stages of controlled rat studies (2016-2019), plus a 2025 Wi-Fi 6 router study. The bees study (2019) extended the model to a different biological system. The 2025 study introduced the first genotype-stratified analysis (LT vs. HT rat strains).

Studies: Animal Model Research Cluster.

4. Multi-Stage Longitudinal Research Programs

What it means: A series of studies conducted sequentially, with each stage building on the findings of the previous one. Endpoints, exposure conditions, and protocols are progressively refined.

Why it matters: Longitudinal programs allow dose-response characterization, replication across conditions, and detection of effects that may only emerge over longer timeframes or across biological systems.

In the Aires corpus: The IFRAN 5-stage rat series (2016-2019) and the Sysoev-Rybina 5-stage EEG protocol (2025) are the two primary examples. Each stage builds methodologically on the previous.

5. Peer-Reviewed Physics Simulation

What it means: Computer modeling (FEM/MEMS simulation) of the device's electromagnetic properties, published in a peer-reviewed scientific venue.

Why it matters: Physics simulation provides mechanistic confirmation independent of biological measurement. A model that accurately predicts the device's electromagnetic behavior supports (but does not prove) the proposed biological mechanism.

In the Aires corpus: Lukyanov, Kopyltsov & Serov (Springer, ICICT 2022) published the first peer-reviewed mathematical model of the Lifetune resonator's electromagnetic response. Lukyanov (ICICT 2026) followed with thermal imaging physical confirmation. Both published via Springer.

6. Independent Technical Evaluation (Engineering Peer Review)

What it means: An independent engineering institution tests and characterizes the device's electromagnetic properties using calibrated laboratory equipment, without commercial involvement.

Why it matters: Engineering peer review confirms the device's physical mechanism independent of biological claims. A device with confirmed electromagnetic properties is more credible than one whose mechanism is uncharacterized.

In the Aires corpus: VGTU (Vilnius Gediminas Technical University, Lithuania) conducted a three-phase independent evaluation (2016-2018), characterizing the resonator-converter's interference behavior across the RF spectrum.

7. Expert Peer Review by Independent NGO

What it means: Independent scientific experts review published studies and provide written assessment of methodology, findings, and conclusions — without being employed by the company.

Why it matters: Expert review adds a layer of evaluation above the original authors. PACE's UN ECOSOC affiliation provides a formal institutional standing for these reviews.

In the Aires corpus: Seven independent expert reviews by PACE (Planetary Association for Clean Energy, UN ECOSOC NGO) between 2018-2019. Each review assesses a specific study's methodology and findings.

What the Research Does and Does Not Claim

The Aires research corpus consistently reports biological normalization effects — measurements showing that biological parameters disturbed by EMF exposure return toward baseline values when an Aires device is present. This is what the research shows across multiple endpoints, institutions, and years.

What the research does not establish at this stage:

• Causal cellular mechanism: The studies document biological effects but do not fully characterize the molecular pathway by which incoherent-to-coherent field transformation affects cellular biology
• Population-level clinical efficacy: Most studies are relatively small by pharmaceutical trial standards. The Havas placebo-controlled studies were case studies (individual subjects), not large randomized controlled trials
• Regulatory approval: The devices are not FDA-cleared medical devices; they are consumer electronics

These limitations are noted transparently across the research archive. The strength of the evidence lies in consistency across 60+ studies, replication across multiple institutions, and the published peer-reviewed physics confirmation of the mechanism.

Evaluation Framework: Questions to Ask of Any EMF Research

1. Who conducted the research? Is the institution independent of the manufacturer?
2. What biological endpoints were measured? Are these validated, objective measurements?
3. Was the EMF source active during testing? (Blocking cannot be the mechanism if the device still functions)
4. Was there a control condition? What was compared against what?
5. Has the study been replicated? By independent groups?
6. Is the mechanism physically characterized? Is there a patent, simulation, or physical measurement of the device's properties?
7. Has the research been peer reviewed? By whom, and in what venue?

---